Quick Takeaways
- ROYCE & ASSOCIATES LP filed SCHEDULE 13G/A for OptimizeRx Corp Common Stock (OPRX).
- Disclosed ownership: 4.3%.
- Date of event: 30 Jun 2025.
ROYCE & ASSOCIATES LP - 30 Jun 2025 SCHEDULE 13G/A Report for OptimizeRx Corp Common Stock (OPRX)
- Filing Manager
- ROYCE & ASSOCIATES LP
- Reporting Manager
- ROYCE & ASSOCIATES LP
- Security
- OptimizeRx Corp Common Stock
- Symbol
- OPRX
- Shares outstanding
- 18,516,159 shares
- Disclosed Ownership
- 790,640 shares
- Ownership
- 4.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 16 Jul 2025, 11:35:41 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 28 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ROYCE & ASSOCIATES LP disclosed 4.3% ownership in OptimizeRx Corp Common Stock (OPRX) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 28 Jan 2025.
- Current filing was accepted on 16 Jul 2025, 11:35.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ROYCE & ASSOCIATES LP | 4.3% | 790,640 | 790,640 | 0 | Daniel A. O'Byrne | Vice President |